The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A potential novel therapeutic target for invasive soft tissue sarcoma detected through tumor immune microenvironment and genetic profile analyses.
 
Akane Ariga
No Relationships to Disclose
 
Yuki Funauchi
No Relationships to Disclose
 
Yukari Kobayashi
No Relationships to Disclose
 
Koji Nagaoka
No Relationships to Disclose
 
Yasuyoshi Sato
No Relationships to Disclose
 
Shingo Sato
No Relationships to Disclose
 
Toshitaka Yoshii
No Relationships to Disclose
 
Keisuke Ae
No Relationships to Disclose
 
Shunji Takahashi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer/EMD Serono (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Kazuhiro Kakimi
No Relationships to Disclose